UK registered organisations can apply for grants to fund industrial research projects focused on manufacturing innovation for nucleic acid medicines.

This Innovate UK (IUK) competition aims to improve the resource efficiency, productivity and scalability for the manufacture of nucleic acid medicines in the UK. This will be achieved by stimulating the development and implementation of innovative technologies. This must allow for growth at scale including, but not limited to, emerging products targeting large patient populations.

Projects must be focused on the manufacturing of the active nucleic acid ingredient. Applicants must be able to demonstrate an improvement in resource efficiency, productivity or throughput as compared with current manufacturing technology utilising a recognised metric, for example, with process mass intensity.

Up to £5 million has been allocated to fund industrial research projects in this competition. Funding will be in the form of a grant. Each project’s total grant funding request must be between £100,000 and £2 million.

Funding proposals must show how the project will improve the productivity, competitiveness and growth for at least one UK small or medium-sized enterprise (SME) involved in the project.

This competition is open to collaborations only, undertaken by UK registered businesses research and technology organisations (RTOs), non-profits or public sector organisations Applications must involve at least one grant claiming micro or SME business. Academic institutions cannot lead or work alone but can be part of a collaborative bid.

The competition opens on 7 November 2022. The deadline for applications is 21 December 2022 (11:00 GMT).

How To Apply

The competition opens on 7 November 2022. The deadline for applications is 21 December 2022 (11:00 GMT).

Applications are made online.

More information is available at the Innovate UK website.